Epidermal Growth Factor Receptor Inhibitors: Cutaneous Side Effects and Their Management [0.03%]
表皮生长因子受体抑制剂的皮肤副作用及其处理方法
S Monjazeb,J Wilson
S Monjazeb
Epidermal growth factor receptor (EGFR) inhibitors are part of an emerging class of anticancer medicines known as "targeted therapy," which target pathways more specific to neoplastic proliferation than traditional chemotherapeutic agents. ...
Review
Skin therapy letter. 2017 Sep;22(5):5-7. DOI: 2017
Vitamin B Derivative (Nicotinamide)Appears to Reduce Skin Cancer Risk [0.03%]
维生素B衍生物(烟酰胺)似乎可以降低皮肤癌的风险
S Nazarali,P Kuzel
S Nazarali
Nicotinamide, an amide form of vitamin B3, has shown the potential to treat a variety of dermatological conditions, including acne, rosacea, and atopic dermatitis. Recent studies have demonstrated the role of nicotinamide, in both topical a...
Review
Skin therapy letter. 2017 Sep;22(5):1-4. DOI: 2017
P Grewal,R Sanghera
P Grewal
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are common, worldwide viral illnesses that potentially impact the clinician's ability to manage patients with immunosuppressive medications such as biological therapy. In light of recent l...
Review
Skin therapy letter. 2017 Jul;22(4):7-9. DOI: 2017
Secukinumab in the Treatment of Psoriasis and Psoriatic Arthritis: A Review of the Literature [0.03%]
苏金单抗治疗银屑病和银屑病关节炎的临床研究进展
M Abrouk,J Gandy,M Nakamura et al.
M Abrouk et al.
While there are several commercially available treatment options for psoriasis and psoriatic arthritis, there remains a large number of individuals who are refractory to current modalities. In the recent past, there has been increasing evid...
Review
Skin therapy letter. 2017 Jul;22(4):1-6. DOI: 2017
C Zip
C Zip
A triad approach to the treatment of acne and rosacea has been recommended. This integrated management approach includes patient education, selection of therapeutic agents, and initiation of an appropriate skin care regime. Proper skin care...
Review
Skin therapy letter. 2017 May;22(3):5-7. DOI: 2017
C Zip
C Zip
A triad approach to the treatment of acne and rosacea has been recommended. This integrated management approach includes patient education, selection of therapeutic agents, and initiation of an appropriate skin care regime. Proper skin care...
Review
Skin therapy letter. 2017 May;22(3):5-7. DOI: 2017
M N Nicholas,M Gooderham
M N Nicholas
Psoriasis is a chronic condition that affects the well-being and quality of life of patients. The disease is associated with an increased risk of depression and suicidality, which may not be fully understood by the general population. It is...
Review
Skin therapy letter. 2017 May;22(3):1-4. DOI: 2017
A Review of Guselkumab, an IL-23 Inhibitor, for Moderate-to-Severe Plaque Psoriasis [0.03%]
Guselkumab(IL-23抑制剂)治疗中至重度斑块状银屑病的疗效及安全性：一项综述研究
Z Nawas,M Hatch,E Ramos et al.
Z Nawas et al.
Psoriasis is a chronic inflammatory skin disorder that affects 2% of the population. Evidence suggests that interleukin (IL)-23 plays a pivotal role in the pathogenesis of psoriasis. Guselkumab is a subcutaneously administered, humanized an...
Review
Skin therapy letter. 2017 Mar;22(2):8-10. DOI: 2017
Tofacitinib in the Treatment of Rheumatoid Arthritis and Chronic Plaque Psoriasis [0.03%]
托法替尼治疗类风湿性关节炎和慢性斑块状银屑病研究进展
A K Gupta,M Cernea,C W Lynde
A K Gupta
Tofacitinib is an oral immunosuppressant approved for the treatment of rheumatoid arthritis (RA) and is currently undergoing investigation (Phase III trials) for treating chronic plaque psoriasis. Tofacitinib inhibits Janus kinases (JAKs), ...
Review
Skin therapy letter. 2017 Mar;22(2):1-7. DOI: 2017
A Dermatologist's Guide to Infection Screening Prior to Initiating Immunosuppressive Therapy [0.03%]
皮肤病学家制定的启动免疫抑制治疗前感染筛查指南
M G Ponzo,C H Hong
M G Ponzo
Dermatologists have within their armamentarium numerous immunosuppressant agents, both traditional and new, that are useful in the treatment of chronic cutaneous disorders such as autoimmune bullous diseases and psoriasis. It is imperative ...
Review
Skin therapy letter. 2017 Jan;22(1):8-11. DOI: 2017